Literature DB >> 24071006

A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.

Dongyan Liu1, Connie J Wang, Daniel P Judge, Marc K Halushka, Jie Ni, Jennifer P Habashi, Javid Moslehi, Djahida Bedja, Kathleen L Gabrielson, Hangxue Xu, Feng Qian, David Huso, Harry C Dietz, Gregory G Germino, Terry Watnick.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of renal failure that is due to mutations in two genes, PKD1 and PKD2. Vascular complications, including aneurysms, are a well recognized feature of ADPKD, and a subgroup of families exhibits traits reminiscent of Marfan syndrome (MFS). MFS is caused by mutations in fibrillin-1 (FBN1), which encodes an extracellular matrix protein with homology to latent TGF-β binding proteins. It was recently demonstrated that fibrillin-1 deficiency is associated with upregulation of TGF-β signaling. We investigated the overlap between ADPKD and MFS by breeding mice with targeted mutations in Pkd1 and Fbn1. Double heterozygotes displayed an exacerbation of the typical Fbn1 heterozygous aortic phenotype. We show that the basis of this genetic interaction results from further upregulation of TGF-β signaling caused by Pkd1 haploinsufficiency. In addition, we demonstrate that loss of PKD1 alone is sufficient to induce a heightened responsiveness to TGF-β. Our data link the interaction of two important diseases to a fundamental signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24071006      PMCID: PMC3871766          DOI: 10.1681/ASN.2012050486

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  63 in total

1.  Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.

Authors:  N Fukuda; W Y Hu; A Kubo; H Kishioka; C Satoh; M Soma; Y Izumi; K Kanmatsuse
Journal:  Am J Hypertens       Date:  2000-02       Impact factor: 2.689

2.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

3.  Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta.

Authors:  S Topouzis; M W Majesky
Journal:  Dev Biol       Date:  1996-09-15       Impact factor: 3.582

4.  Vascular expression of polycystin.

Authors:  M D Griffin; V E Torres; J P Grande; R Kumar
Journal:  J Am Soc Nephrol       Date:  1997-04       Impact factor: 10.121

5.  Dissecting aneurysm in a patient with autosomal dominant polycystic kidney disease.

Authors:  Naoto Fukunaga; Mitsuru Yuzaki; Michihiro Nasu; Yukikatsu Okada
Journal:  Ann Thorac Cardiovasc Surg       Date:  2012-01-31       Impact factor: 1.520

Review 6.  Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis.

Authors:  Christiane Rüster; Gunter Wolf
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

7.  Polycystin 1 is required for the structural integrity of blood vessels.

Authors:  K Kim; I Drummond; O Ibraghimov-Beskrovnaya; K Klinger; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Abdominal visceral findings in patients with Marfan syndrome.

Authors:  Kira Chow; Reed E Pyeritz; Harold I Litt
Journal:  Genet Med       Date:  2007-04       Impact factor: 8.822

9.  A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo.

Authors:  Klaus B Piontek; David L Huso; Alexander Grinberg; Lijuan Liu; Djahida Bedja; Haidan Zhao; Kathleen Gabrielson; Feng Qian; Changlin Mei; Heiner Westphal; Gregory G Germino
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

10.  A kindred exhibiting cosegregation of an overlap connective tissue disorder and the chromosome 16 linked form of autosomal dominant polycystic kidney disease.

Authors:  S Somlo; G Rutecki; L A Giuffra; S T Reeders; A Cugino; F C Whittier
Journal:  J Am Soc Nephrol       Date:  1993-12       Impact factor: 10.121

View more
  19 in total

1.  Polycystic kidney disease: TGF-β signalling and vascular complications in ADPKD.

Authors:  Ellen F Carney
Journal:  Nat Rev Nephrol       Date:  2013-10-15       Impact factor: 28.314

2.  Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

Authors:  Ao Li; Yuchen Xu; Song Fan; Jialin Meng; Xufeng Shen; Qian Xiao; Yuan Li; Li Zhang; Xiansheng Zhang; Guanqing Wu; Chaozhao Liang; Dianqing Wu
Journal:  JCI Insight       Date:  2018-03-08

3.  Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.

Authors:  Ao Li; Xin Tian; Xiaoli Zhang; Shunwei Huang; Yujie Ma; Dianqing Wu; Gilbert Moeckel; Stefan Somlo; Guanqing Wu
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

4.  Adipose tissue loss and lipodystrophy in xylosyltransferase II deficient mice.

Authors:  Pulavendran Sivasami; Nabin Poudel; Maria Cristina Munteanu; Joanna Hudson; Pamela Lovern; Lin Liu; Tim Griffin; Myron E Hinsdale
Journal:  Int J Obes (Lond)       Date:  2019-02-18       Impact factor: 5.095

Review 5.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

Review 6.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

7.  Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Abdullah Ozkok; Qian Wang; Adam E Mullick; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-23

Review 8.  Ciliary Mechanisms of Cyst Formation in Polycystic Kidney Disease.

Authors:  Ming Ma; Anna-Rachel Gallagher; Stefan Somlo
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

Review 9.  Vascular complications in autosomal dominant polycystic kidney disease.

Authors:  Ronald D Perrone; Adel M Malek; Terry Watnick
Journal:  Nat Rev Nephrol       Date:  2015-08-11       Impact factor: 28.314

Review 10.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.